The goal of Semaglutide is to shift the set point of your hunger
Prioritize protein at every meal Protein is one of the strongest dietary triggers for GLP-1 release
Phaze is currently iOS-first
Genetic evidence, such as GWAS, has identified the single-nucleotide polymorphism (SNP) in GIPR, showing that lower function of GIPR is associated with lower BMI (6466), allowing speculation that higher GIPR activity is obesity promoting
Cardiovascular benefits Certain GLP-1 agonists (such as semaglutide and liraglutide) have been shown to reduce the risk of major cardiovascular events, particularly in people with existing heart disease or high cardiovascular risk
It's worth highlighting, though, that poorly controlled diabetes itself elevates the risk of gastroparesis